This firm fixed-price delivery order contract was awarded by the Defense agency Medical Supply Chain to Glaxosmithkline, LLC for the supply of the antiviral medication zanamivir for inhalation. The $1,532,034 contract has a completion date of December 15, 2016 and was not set aside for any special designation. Glaxosmithkline, a pharmaceutical company that provides vaccines, antivirals, and other products to government agencies, has received multiple federal contracts and grants to support disease prevention, immunization programs, and healthcare services. This order falls under a larger $4.6 million indefinite delivery vehicle with the Defense Logistics Agency Troop Support to provide zanamivir. Glaxosmithkline has also held other federal contracts with the VA, CDC, and DoD for influenza vaccines, vaccine storage, and COVID-19 therapeutics.